2 recruiting. 1 Early Phase 1, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Recruiting 1 |
| Not applicable | 1 | Recruiting 1 |
Follow Daniel Morgenstern: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Pilot Study Investigating Upfront Adaptive Immunotherapy Approach in Children, Adolescent and Young Adult (CAYA) Patients With Replication-Repair Deficient (RRD) High-Grade Gliomas (HGG) Nivolumab, Radiation - High Grade Glioma, Replication Repair Deficient | Not applicable | Recruiting | Daniel Morgenstern | 20 | 2024-12-06 | 2025-08-29 |
| Pilot Study of Vinblastine and Tovorafenib in Pediatric Patients With Recurrent/Progressive RAF Altered Low Grade Gliomas Tovorafenib, Vinblastine - Low-grade Glioma | Early Phase 1 | Recruiting | Daniel Morgenstern | 57 | 2024-03-21 | 2025-05-15 |
Glioma (1)
Nivolumab (1) · Radiation (1) · Vinblastine (1) · tovorafenib (1)
Canada (2)